GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is a publicly traded Healthcare sector company. As of September 6, 2026, GSK trades at $49.93 with a market cap of $99.96B and a P/E ratio of 0.00. GSK moved -1.89% today. Year to date, GSK is +0.52%; over the trailing twelve months it is +23.19%. Its 52-week range spans $31.72 to $61.70. Analyst consensus is buy with an average price target of $70.00. Rallies surfaces GSK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GSK insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $49.93 |
| Market Cap | $99.96B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.45% |
| 52-Week High | $61.70 |
| 52-Week Low | $31.72 |
| Volume | 2.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover GSK: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $70.00.